TUCCI, MARCO GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 6.595
EU - Europa 1.465
AS - Asia 482
OC - Oceania 5
SA - Sud America 5
AF - Africa 1
Totale 8.553
Nazione #
US - Stati Uniti d'America 6.592
SE - Svezia 508
CN - Cina 387
IT - Italia 277
UA - Ucraina 177
DE - Germania 140
GB - Regno Unito 119
FI - Finlandia 102
FR - Francia 51
BE - Belgio 33
VN - Vietnam 31
IN - India 18
IE - Irlanda 17
IR - Iran 14
JP - Giappone 9
NL - Olanda 9
HK - Hong Kong 7
AT - Austria 5
RO - Romania 5
RU - Federazione Russa 5
BR - Brasile 4
GR - Grecia 4
AL - Albania 3
AU - Australia 3
CA - Canada 3
DK - Danimarca 3
HR - Croazia 3
PH - Filippine 3
PK - Pakistan 3
ES - Italia 2
ID - Indonesia 2
KR - Corea 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
IL - Israele 1
MK - Macedonia 1
PL - Polonia 1
SG - Singapore 1
TR - Turchia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 8.553
Città #
Fairfield 934
Chandler 724
Woodbridge 634
Ashburn 463
Nyköping 428
Jacksonville 426
Houston 409
Seattle 370
Cambridge 364
Wilmington 298
Ann Arbor 270
Lawrence 158
Roxbury 151
Beijing 124
Nanjing 114
Des Moines 98
New York 78
Princeton 76
Inglewood 62
Bari 55
Boardman 51
San Diego 48
Brooklyn 37
Brussels 33
Redwood City 33
Dong Ket 31
Paris 28
Shenyang 25
Hebei 23
Nanchang 23
Dearborn 20
London 18
Dublin 17
Los Angeles 16
Tianjin 15
San Mateo 14
Arzano 11
Helsinki 11
Marseille 11
Taranto 11
Jiaxing 10
Augusta 9
Hōrai 9
Washington 9
Changsha 8
Hounslow 8
Bologna 7
Hefei 7
Milan 7
Rome 7
Ardabil 6
Chicago 6
Hong Kong 6
Pune 6
Terlizzi 6
Triggiano 6
Auburn Hills 5
Edinburgh 5
Falls Church 5
Jinan 5
Kilburn 5
Kunming 5
Prescot 5
Redmond 5
Candela 4
Chiswick 4
Grafing 4
Guangzhou 4
Modugno 4
Moscow 4
New Bedfont 4
Norwalk 4
Tehran 4
Acton 3
Canberra 3
Catania 3
General Mariano Alvarez 3
Hangzhou 3
Leawood 3
Molfetta 3
Monmouth Junction 3
New Delhi 3
Ningbo 3
Phoenix 3
Taizhou 3
Vienna 3
Zagreb 3
Adelfia 2
Amsterdam 2
Assago 2
Baotou 2
Cagliari 2
Costa Mesa 2
Cutrofiano 2
Frederiksberg 2
Grumo Appula 2
Hyderabad 2
Lienz 2
Livorno 2
Madrid 2
Totale 6.973
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 161
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 122
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 119
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 113
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 108
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 106
Cytotherapies in multiple myeloma: a complementary approach to current treatments 105
null 103
Does cilengitide deserve another chance? 103
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 102
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 101
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 101
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 100
Avβ3 integrin: Pathogenetic role in osteotropic tumors 100
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 97
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 97
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 97
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 96
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 95
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 93
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 90
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 89
Adenocarcinoma of the ceruminous glands: role of the VMAT 88
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis 87
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 85
null 85
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 85
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 84
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 82
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. 82
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 81
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 81
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 81
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 79
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients 78
Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus 78
null 78
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 77
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 76
The immune escape in melanoma: role of the impaired dendritic cell function 75
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 75
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 71
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression 70
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 70
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 70
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 69
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 69
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia 69
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis 69
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 69
VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease 68
Increased IL-18 production by dendritic cells in active inflammatory myopathies 67
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. 67
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 66
null 66
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 65
The interplay of chemokines and dendritic cells in the pathogenesis of lupus nephritis 65
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 65
Urinary biomarkers in lupus nephritis 64
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 64
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia 63
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells 62
null 62
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 61
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 61
A new tool for the evaluation of disease activity in lupus nephritis: Urinary monocyte chemoattractant protein (MCP)-1. 59
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 58
null 57
Bone metastases in soft tissue sarcoma patients: a survey of natural, prognostic value and treatment 57
Is measurement of IL-10 useful for disease management in SLE? 56
A functional polymorphism in the monocyte chemoattractant protein (MCP)-1 promoter gene is strongly associated with lupus nephritis 56
A functional polymorphism in the monocyte chemoattractant protein (MCP) - 1 promoter gene is strongly associated with lupus nephritis 56
L'eritropoietina umana nel trattamento dell'anemia associata al mieloma multiplo: potenziale effetto mitogeno sui linfociti B 56
The DOG1 scoring system in GIST: a novel factor for measurement of the recurrence risk 56
Role of active drug transporters in refractory multiple myeloma 55
Antiphosphatidylserine antibodies in human immunodeficiency virus-1(+) patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 55
Alphavbeta3 (AVB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 54
Th1 cytokines in the pathogenesis of lupus nephritis: The role of IL-18 54
Bone-Resorbing Cells in Multiple Myeloma: Osteoclasts, Myeloma Cell Polykaryons, or Both? 54
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 54
Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma 53
IL-12 overexpression and defective TH2 response in lupus nephritis 52
Alpha(V)Beta(3) (alpha(v)beta(3)) integrin drives the osteoclastogenesis through a osteoclast-like functional differentiation of myeloma cells 51
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 51
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 51
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 51
Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis 49
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). 48
Attivazione dell'osteoclastogenesi nel mieloma multiplo: ruolo della transdifferenziazione plasmacellulare 47
Il "rene mielomatoso": aspetti patogenetici e clinici 45
Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies 45
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 45
miRNAs in melanoma: a defined role in tumor progression and metastasis 45
L'alterata compliance diastolica nell'ipertensione arteriosa primitiva: ruolo dell'iperattività adrenergica nella fase pre-ipertrofica 44
Vasculiti primarie sistemiche 43
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 43
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 42
Deregulated apoptosis of highly malignant myeloma cells plays a pathogenetic role in tumor progression 41
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 41
BONE METASTASES IN NEUROENDOCRINE TUMORS: MOLECULAR PATHOGENESIS AND IMPLICATIONS IN CLINICAL PRACTICE. 41
Totale 7.192
Categoria #
all - tutte 41.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019572 0 0 0 0 0 0 0 0 0 114 235 223
2019/20202.151 308 133 63 185 229 136 212 185 261 152 215 72
2020/20211.835 141 103 155 173 209 144 225 151 119 194 120 101
2021/20221.131 65 139 16 58 58 82 37 53 77 86 198 262
2022/20231.959 294 235 129 161 198 263 41 240 304 17 48 29
2023/2024633 63 135 45 108 67 129 24 37 9 16 0 0
Totale 9.011